Atos Scientific community
The Atos Scientific Community aims at crafting the Group’s vision for the future of technology in business, and anticipating the upcoming trends and technologies that will reshape businesses and society in the years ahead.
This global network comprises 170 of the top scientists, engineers and forward thinkers from across the Group, with a rich mix of skills and backgrounds.
Latest publications
Journey report
Unlocking virtual dimensions
Explore the forces that will shape digital enterprise over the next four years
Opinion Paper
Business Antifragility
Aiming to simply survive a crisis is not enough in today’s disruptive times. What does it take to thrive in a crisis? Is it possible for a business to become antifragile? This paper will share insights and actionable steps to achieve antifragility.
Opinion Paper
Ecosystem dynamics: Understanding dominance and centrality in innovative ecosystems
How do innovation partners collaborate? Read this paper for our analysis of the different strategies we encounter in the FinTech innovation ecosystem.
White Paper
Shared Cross-Reality Collaboration: The fourth dimension of digital human interaction
This paper provides information on spatialized digital human interaction across mixed reality spheres.
White Paper
A 2021 perspective on edge computing
This paper provides a review on the state-of-the-art and today’s edge computing practices, specifically focusing on the software tools that enable the execution of workloads at the edge.
Digitally-enabled precision healthcare – Read the case studies
How Atos enables clients to deliver digitally-enabled precision healthcare with non-contact patient triage and monitoring
Governments and corporations are moving fast to develop novel solutions to address the pandemic situation, such as introducing contact tracing apps by governments and initiating new collaborations between corporations.
Read more
How Atos enables clients to integrate exposomics in digitally-enabled precision healthcare
The Centers for Disease Control and Prevention (CDC) defines exposome as “the measure of all the exposures of an individual in a lifetime and how those exposures relate to health”. Exposomics, the study of exposome, complements genomics, which is the basis for precision medicine.
Read more
How Atos enables life science organizations to deliver innovations in precision medicine
Advances in genomics research and in other areas of life sciences powered and enabled by technology takes the entire value chain to the next level allowing the implementation of the different facets of precision medicine.
Read more